对一般化肌痛性骨髓灰质炎患者新型治疗方法的风险效益分析
A Gordon Smith1, Gil I Wolfe2, Ali A Habib3
1Department of Neurology, Virginia Commonwealth University, Richmond, VA, USA.
Advances in therapy
|October 29, 2024
概括
埃夫加蒂格莫德IV在治疗一般化肌痛性肌痛症 (gMG) 中表现出最佳的疗效和经济价值. 与其他治疗方法相比,这种FcRn抑制剂显示出有利的治疗所需数量 (NNT) 和每改善结果的成本 (CPIO).
科学领域:
- 神经学 神经学
- 药物经济学 药物经济学
- 临床试验 临床试验
背景情况:
- 一般化肌痛性肌痛症 (gMG) 是一种影响神经肌肉传播的自身免疫性疾病.
- 抗乙胆受体抗体阳性 (anti-AChR Ab+) gMG代表了一种需要有效治疗的重要亚型.
- 最近的进展包括新生儿Fc受体 (FcRn) 抑制剂和补充抑制剂.
研究的目的:
- 为了比较新型GMG治疗的疗效,安全性和成本效益.
- 为了为抗AChR Ab+ gMG管理的临床决策提供信息.
- 评估需要治疗的数量 (NNT),需要伤害的数量 (NNH) 和每改善结果的成本 (CPIO).
主要方法:
- 对FcRn抑制剂 (efgartigimod IV,rozanolixizumab) 和补充抑制剂 (ravulizumab,zilucoplan) 与安慰剂的临床试验的网络元分析 (NMA).
- 根据疗效和安全结果估计NNT和NNH.
- 使用2024美元计算CPIO,用于QMG和MG-ADL得分的改善.
- 敏感性分析包括efgartigimod PH20 SC和eculizumab.
主要成果:
- 埃夫加蒂格莫德IV显示了QMG和MG-ADL得分改善的最低NNT.
- 罗扎诺利克西祖马布显示了最低的NNT,降低了MG-ADL≥3个点.
- 在不同治疗方法中,NNH是可比的;efgartigimod IV在所有疗效结局中具有最低的CPIO.
- 敏感性分析证实efgartigimod PH20 SC与efgartigimod IV相比较的NNT/CPIO;eculizumab显示CPIO更高.
结论:
- FcRn 抑制剂和补充抑制剂为抗AChR Ab+ gMG提供了临床益处,具有可接受的安全性.
- 与拉夫利祖马布,罗扎诺利克西祖马布和齐卢科普兰相比,Efgartigimod显示出有利的益处风险概况和经济价值.
- 埃夫加尔蒂基莫德IV是抗AChR Ab+ gMG.的成本有效的治疗选择.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Myasthenia Gravis: Diagnostic Tests
673
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
673
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
618
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
618
Skeletal Muscle Relaxants: Therapeutic Uses
468
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
468
Direct-Acting Cholinergic Agonists: Therapeutic Uses
693
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
693
Skeletal Muscle Relaxants: Adverse Effects
338
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
338


